Decomit Metered-Dose Inhaler (MDI) | 50mcg/puff

✔️ Dosage

Beclometasone Dipropionate Inhaler is intended for oral inhalation only. The initial dose should be selected based on the severity of asthma, then adjusted to achieve optimal control and subsequently reduced to the lowest effective maintenance dose.

Adults (including elderly)

Usual starting dose: 200 micrograms twice daily

Severe asthma: May require 600–800 micrograms per day initially

Once control is achieved, the dose should be gradually reduced

Total daily dose may be administered in 2, 3, or 4 divided doses

Children

Usual starting dose: 100 micrograms twice daily

Alternatively, 50–100 micrograms may be given 2–4 times daily depending on clinical response

Beclometasone 250 Inhaler is not recommended for children

✔️ Side Effects

Systemic effects may occur, particularly with high doses or prolonged use, including:

Cushing’s syndrome or Cushingoid features

Adrenal suppression

Growth retardation in children and adolescents

Reduced bone mineral density

Cataract and glaucoma

✔️ Cleaning Instructions:

Clean the inhaler once weekly. Remove the metal canister and wash the plastic actuator and cap in warm water. Do not immerse the canister in water. Dry thoroughly before reassembly.

✔️ Administration

Correct inhaler technique is essential to ensure adequate drug delivery to the lungs and optimal asthma control.

Steps for proper use:

• Remove the mouthpiece cap.
• Shake the inhaler vigorously at least six times before each use.
• If unused for one week or more, release one test spray into the air.
• Exhale fully and hold the inhaler upright.
• Place the mouthpiece between the teeth and seal lips around it.
• Inhale slowly and deeply while pressing down firmly on the canister.
• Remove the inhaler and hold breath for at least 10 seconds or as long as comfortable.
• If additional doses are prescribed, wait 1 minute between puffs and repeat the steps.
• Replace the cap and rinse the mouth with water after use.

✔️ Pregnancy & Lactation

There is insufficient evidence regarding the safety of beclometasone dipropionate in human pregnancy. Animal studies have shown fetal abnormalities, including cleft palate and intrauterine growth retardation. Use during pregnancy should be considered only if the potential benefit outweighs the risk.

In breastfeeding women, therapy should be initiated after carefully weighing the benefits to the mother against potential risks to the infant.

✔️ Contraindications:

Known hypersensitivity to beclometasone dipropionate or any formulation component

Use with caution in patients with active or latent pulmonary tuberculosis

✔️ Precautions & Warnings

Patients should be educated on correct inhaler technique, and regular assessment of technique is recommended to ensure effective lung deposition. The inhaler must be used daily and regularly, even in the absence of symptoms, to maintain asthma control.

✔️ Storage:

Store below 30°C, protected from direct sunlight and heat.
Do not puncture, break, or burn the canister, even when empty.
Avoid contact with eyes.
Keep out of the reach of children.